Clinical Trials Browser

Phase 2 × Recruiting × Thymalfasin × Clear all

NCT06461910 2026-03-03

Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma

Phase 2 Recruiting

Gastrointestinal

Stomach Neoplasms

NCT06829355 2025-02-17

THYMI

Phase 2 Recruiting

MCRC

NCT06584006 2024-09-19

Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors

Phase 2 Recruiting

Other hematologic neoplasm

Lymphopenia, Hematologic Neoplasms